Related Experiment Videos
Is antilymphocytic globulin a better immunosuppressant than cyclophosphamide for pure red cell aplasia?
British Journal of Haematology
|April 1, 1984
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Allogeneic hematopoietic SCT for patients with autoimmune diseases.
Bone marrow transplantation·2009
Autologous stem cell transplantation for severe autoimmune diseases: a 10-year experience.
Annals of the New York Academy of Sciences·2007
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2006
Autologous hematopoietic stem cell transplantation for autoimmune diseases.
Bone marrow transplantation·2005
Outcome heterogeneity in CALR-mutated myeloproliferative neoplasms.
British journal of haematology·2026
SENIOR-IPI: An easily applicable prognostic index for first-line large B-cell lymphomas patients >80 years treated with curative intent.
British journal of haematology·2026
CALR-mutated myeloproliferative neoplasms: Refining molecular risk beyond the driver.
British journal of haematology·2026
RESOLVE to do better.
British journal of haematology·2026
From oncogenesis to approval: the lentiviral gene therapy revolution in Wiskott-Aldrich syndrome.
Regenerative medicine·2026
Primary extranodal marginal zone lymphoma of gastric mucosa-associated lymphoid tissue in children: a case report and review of the literature.
Journal of medical case reports·2026
Beyond MYD88-only testing: MYD88/CD79B profiling improves molecular detection and MCD genotyping in VRL and CNS lymphomas.
Experimental hematology & oncology·2026
Geranylgeranylation is required for B-cell proliferation and plasma cell survival implications for autoimmune therapy.
Cellular & molecular immunology·2026
A microbiota-driven CCL25-CCR9 axis reprograms intestinal ILC2s in the distal small intestine to promote metabolic dysfunction in obesity.
Cellular and molecular gastroenterology and hepatology·2026